Discovery and characterization of novel inhibitors of CTP synthase 1 (CTPS1) for the treatment of autoimmune and inflammatory disease
Joshua McElwee(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), Michael A. DiMattia(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Eric M. Lynch(University of Washington), K. D. Kreutter(Nimbus (Italy)), Sébastien Campos(Pharmaron (United Kingdom)), Justin M. Kollman(University of Washington), Angela V. Toms, Kevin R. DeMarco(Schrodinger (United States)), Justin A. Caravella(Rockefeller University Press), Samantha Carreiro(Ensemble Therapeutics (United States)), Avinash Phadke(Achillion Pharmaceuticals (United States)), Sheetal Kumar(Addenbrooke's Hospital), Suzanne L. Jacques(Nimbus (Italy)), Steven K. Albanese(Schrodinger (United States)), Neelu Kaila, Andreas Verras(Schrodinger (United States))
Cited by 2
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k